Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, frequently leads to end-stage renal disease and kidney transplantation. However, disease recurrence often occurs after transplantation. Here we evaluated the predictive value of three markers for IgAN recurrence: the prese...
Gespeichert in:
| Veröffentlicht in: | Kidney international 2015-10, Vol.88 (4), p.815-822 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 822 |
|---|---|
| container_issue | 4 |
| container_start_page | 815 |
| container_title | Kidney international |
| container_volume | 88 |
| creator | Berthelot, Laureline Robert, Thomas Vuiblet, Vincent Tabary, Thierry Braconnier, Antoine Dramé, Moustapha Toupance, Olivier Rieu, Philippe Monteiro, Renato C. Touré, Fatouma |
| description | IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, frequently leads to end-stage renal disease and kidney transplantation. However, disease recurrence often occurs after transplantation. Here we evaluated the predictive value of three markers for IgAN recurrence: the presence of galactose-deficient IgA1, IgG anti-IgA autoantibodies, and IgA-soluble (s) CD89 complexes. This was analyzed in 38 kidney transplant recipients with IgAN recurrence and compared with 22 patients transplanted for IgAN but without recurrence and with 17 healthy controls. Pre-transplantation galactose-deficient IgA1 serum levels were significantly higher in the recurrence compared with the no recurrence or control groups. IgA–IgG complexes were significantly elevated in the recurrence group. Both the recurrence and no recurrence groups had increased values of IgA–sCD89 complexes compared with healthy controls, but values were significantly lower in patients with recurrence compared with no recurrence. Areas under the receiver operating curve of the markers in pre-transplantation sera were 0.86 for galactose-deficient-IgA, 0.82 for IgA–IgG, and 0.78 for sCD89–IgA; all significant. Disease recurrence was associated with decreased serum galactose-deficient IgA1 and appearance of mesangial-galactose-deficient IgA1 deposits, whereas increased serum IgA–sCD89 complexes were associated with mesangial sCD89 deposits. Thus, galactose-deficient-IgA1, IgG autoantibodies, and IgA–sCD89 complexes are valuable biomarkers to predict disease recurrence, highlighting major pathogenic mechanisms in IgAN. |
| doi_str_mv | 10.1038/ki.2015.158 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1718912742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2157171615322437</els_id><sourcerecordid>1718912742</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-cfaa8a63df1387b7acdb709faeb77842dd564a2240525253f6cc75c282c19433</originalsourceid><addsrcrecordid>eNptkc2LFDEQxYMo7rh68i4BL4L2mI9OJ31cxq-FBUH2HtJJ9W520502Scv2f2-GWT2I1KGo4leP4j2EXlOyp4Srj_d-zwgVeyrUE7SjgvGGSiGeoh0hSjRMcHWGXuR8R-rcc_IcnbGOdFS07Q5NP8CuKcFc8OXNBZ5huU1xMeV2wz7jJYHztoDDw4ZNKFBnfBM2G_MWzHFfjz5gs5Zo5uKH6DxkbGaHcwzrEAAfPqke2zgtAR4gv0TPRhMyvHrs5-j6y-frw7fm6vvXy8PFVWMF70pjR2OU6bgbKVdykMa6QZJ-NDBIqVrmnOhaw1hLBKvFx85aKSxTzNK-5fwcvTvJLin-XCEXPflsIQQzQ1yzppKqnjLZsoq-_Qe9i2ua63NHSoq2Ul2l3p8om2LOCUa9JD-ZtGlK9DEEfe_1MQRdQ6j0m0fNdZjA_WX_uF4BcQKgevDLQ9LZephtNTuBLdpF_1_h34Ggk8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1717542746</pqid></control><display><type>article</type><title>Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Berthelot, Laureline ; Robert, Thomas ; Vuiblet, Vincent ; Tabary, Thierry ; Braconnier, Antoine ; Dramé, Moustapha ; Toupance, Olivier ; Rieu, Philippe ; Monteiro, Renato C. ; Touré, Fatouma</creator><creatorcontrib>Berthelot, Laureline ; Robert, Thomas ; Vuiblet, Vincent ; Tabary, Thierry ; Braconnier, Antoine ; Dramé, Moustapha ; Toupance, Olivier ; Rieu, Philippe ; Monteiro, Renato C. ; Touré, Fatouma</creatorcontrib><description>IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, frequently leads to end-stage renal disease and kidney transplantation. However, disease recurrence often occurs after transplantation. Here we evaluated the predictive value of three markers for IgAN recurrence: the presence of galactose-deficient IgA1, IgG anti-IgA autoantibodies, and IgA-soluble (s) CD89 complexes. This was analyzed in 38 kidney transplant recipients with IgAN recurrence and compared with 22 patients transplanted for IgAN but without recurrence and with 17 healthy controls. Pre-transplantation galactose-deficient IgA1 serum levels were significantly higher in the recurrence compared with the no recurrence or control groups. IgA–IgG complexes were significantly elevated in the recurrence group. Both the recurrence and no recurrence groups had increased values of IgA–sCD89 complexes compared with healthy controls, but values were significantly lower in patients with recurrence compared with no recurrence. Areas under the receiver operating curve of the markers in pre-transplantation sera were 0.86 for galactose-deficient-IgA, 0.82 for IgA–IgG, and 0.78 for sCD89–IgA; all significant. Disease recurrence was associated with decreased serum galactose-deficient IgA1 and appearance of mesangial-galactose-deficient IgA1 deposits, whereas increased serum IgA–sCD89 complexes were associated with mesangial sCD89 deposits. Thus, galactose-deficient-IgA1, IgG autoantibodies, and IgA–sCD89 complexes are valuable biomarkers to predict disease recurrence, highlighting major pathogenic mechanisms in IgAN.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1038/ki.2015.158</identifier><identifier>PMID: 26061544</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Antigen-Antibody Complex - blood ; Antigens, CD - blood ; Area Under Curve ; Autoantibodies - blood ; autoantibody ; Biomarkers - blood ; Biopsy ; Case-Control Studies ; Disease Progression ; Female ; Glomerulonephritis, IGA - blood ; Glomerulonephritis, IGA - diagnosis ; Glomerulonephritis, IGA - immunology ; Glomerulonephritis, IGA - surgery ; Humans ; IgA glycosylation ; IgA nephropathy ; Immunoglobulin A - blood ; Kidney - immunology ; Kidney - pathology ; Kidney Failure, Chronic - blood ; Kidney Failure, Chronic - diagnosis ; Kidney Failure, Chronic - immunology ; Kidney Failure, Chronic - surgery ; Kidney Transplantation ; Male ; Middle Aged ; Predictive Value of Tests ; Receptors, Fc - blood ; Recurrence ; Risk Factors ; ROC Curve ; sCD89 ; Treatment Outcome</subject><ispartof>Kidney international, 2015-10, Vol.88 (4), p.815-822</ispartof><rights>2015 International Society of Nephrology</rights><rights>Copyright Nature Publishing Group Oct 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-cfaa8a63df1387b7acdb709faeb77842dd564a2240525253f6cc75c282c19433</citedby><cites>FETCH-LOGICAL-c536t-cfaa8a63df1387b7acdb709faeb77842dd564a2240525253f6cc75c282c19433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26061544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berthelot, Laureline</creatorcontrib><creatorcontrib>Robert, Thomas</creatorcontrib><creatorcontrib>Vuiblet, Vincent</creatorcontrib><creatorcontrib>Tabary, Thierry</creatorcontrib><creatorcontrib>Braconnier, Antoine</creatorcontrib><creatorcontrib>Dramé, Moustapha</creatorcontrib><creatorcontrib>Toupance, Olivier</creatorcontrib><creatorcontrib>Rieu, Philippe</creatorcontrib><creatorcontrib>Monteiro, Renato C.</creatorcontrib><creatorcontrib>Touré, Fatouma</creatorcontrib><title>Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, frequently leads to end-stage renal disease and kidney transplantation. However, disease recurrence often occurs after transplantation. Here we evaluated the predictive value of three markers for IgAN recurrence: the presence of galactose-deficient IgA1, IgG anti-IgA autoantibodies, and IgA-soluble (s) CD89 complexes. This was analyzed in 38 kidney transplant recipients with IgAN recurrence and compared with 22 patients transplanted for IgAN but without recurrence and with 17 healthy controls. Pre-transplantation galactose-deficient IgA1 serum levels were significantly higher in the recurrence compared with the no recurrence or control groups. IgA–IgG complexes were significantly elevated in the recurrence group. Both the recurrence and no recurrence groups had increased values of IgA–sCD89 complexes compared with healthy controls, but values were significantly lower in patients with recurrence compared with no recurrence. Areas under the receiver operating curve of the markers in pre-transplantation sera were 0.86 for galactose-deficient-IgA, 0.82 for IgA–IgG, and 0.78 for sCD89–IgA; all significant. Disease recurrence was associated with decreased serum galactose-deficient IgA1 and appearance of mesangial-galactose-deficient IgA1 deposits, whereas increased serum IgA–sCD89 complexes were associated with mesangial sCD89 deposits. Thus, galactose-deficient-IgA1, IgG autoantibodies, and IgA–sCD89 complexes are valuable biomarkers to predict disease recurrence, highlighting major pathogenic mechanisms in IgAN.</description><subject>Adult</subject><subject>Aged</subject><subject>Antigen-Antibody Complex - blood</subject><subject>Antigens, CD - blood</subject><subject>Area Under Curve</subject><subject>Autoantibodies - blood</subject><subject>autoantibody</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Case-Control Studies</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Glomerulonephritis, IGA - blood</subject><subject>Glomerulonephritis, IGA - diagnosis</subject><subject>Glomerulonephritis, IGA - immunology</subject><subject>Glomerulonephritis, IGA - surgery</subject><subject>Humans</subject><subject>IgA glycosylation</subject><subject>IgA nephropathy</subject><subject>Immunoglobulin A - blood</subject><subject>Kidney - immunology</subject><subject>Kidney - pathology</subject><subject>Kidney Failure, Chronic - blood</subject><subject>Kidney Failure, Chronic - diagnosis</subject><subject>Kidney Failure, Chronic - immunology</subject><subject>Kidney Failure, Chronic - surgery</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Receptors, Fc - blood</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>ROC Curve</subject><subject>sCD89</subject><subject>Treatment Outcome</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkc2LFDEQxYMo7rh68i4BL4L2mI9OJ31cxq-FBUH2HtJJ9W520502Scv2f2-GWT2I1KGo4leP4j2EXlOyp4Srj_d-zwgVeyrUE7SjgvGGSiGeoh0hSjRMcHWGXuR8R-rcc_IcnbGOdFS07Q5NP8CuKcFc8OXNBZ5huU1xMeV2wz7jJYHztoDDw4ZNKFBnfBM2G_MWzHFfjz5gs5Zo5uKH6DxkbGaHcwzrEAAfPqke2zgtAR4gv0TPRhMyvHrs5-j6y-frw7fm6vvXy8PFVWMF70pjR2OU6bgbKVdykMa6QZJ-NDBIqVrmnOhaw1hLBKvFx85aKSxTzNK-5fwcvTvJLin-XCEXPflsIQQzQ1yzppKqnjLZsoq-_Qe9i2ua63NHSoq2Ul2l3p8om2LOCUa9JD-ZtGlK9DEEfe_1MQRdQ6j0m0fNdZjA_WX_uF4BcQKgevDLQ9LZephtNTuBLdpF_1_h34Ggk8w</recordid><startdate>20151001</startdate><enddate>20151001</enddate><creator>Berthelot, Laureline</creator><creator>Robert, Thomas</creator><creator>Vuiblet, Vincent</creator><creator>Tabary, Thierry</creator><creator>Braconnier, Antoine</creator><creator>Dramé, Moustapha</creator><creator>Toupance, Olivier</creator><creator>Rieu, Philippe</creator><creator>Monteiro, Renato C.</creator><creator>Touré, Fatouma</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20151001</creationdate><title>Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes</title><author>Berthelot, Laureline ; Robert, Thomas ; Vuiblet, Vincent ; Tabary, Thierry ; Braconnier, Antoine ; Dramé, Moustapha ; Toupance, Olivier ; Rieu, Philippe ; Monteiro, Renato C. ; Touré, Fatouma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-cfaa8a63df1387b7acdb709faeb77842dd564a2240525253f6cc75c282c19433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antigen-Antibody Complex - blood</topic><topic>Antigens, CD - blood</topic><topic>Area Under Curve</topic><topic>Autoantibodies - blood</topic><topic>autoantibody</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Case-Control Studies</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Glomerulonephritis, IGA - blood</topic><topic>Glomerulonephritis, IGA - diagnosis</topic><topic>Glomerulonephritis, IGA - immunology</topic><topic>Glomerulonephritis, IGA - surgery</topic><topic>Humans</topic><topic>IgA glycosylation</topic><topic>IgA nephropathy</topic><topic>Immunoglobulin A - blood</topic><topic>Kidney - immunology</topic><topic>Kidney - pathology</topic><topic>Kidney Failure, Chronic - blood</topic><topic>Kidney Failure, Chronic - diagnosis</topic><topic>Kidney Failure, Chronic - immunology</topic><topic>Kidney Failure, Chronic - surgery</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Receptors, Fc - blood</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>ROC Curve</topic><topic>sCD89</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berthelot, Laureline</creatorcontrib><creatorcontrib>Robert, Thomas</creatorcontrib><creatorcontrib>Vuiblet, Vincent</creatorcontrib><creatorcontrib>Tabary, Thierry</creatorcontrib><creatorcontrib>Braconnier, Antoine</creatorcontrib><creatorcontrib>Dramé, Moustapha</creatorcontrib><creatorcontrib>Toupance, Olivier</creatorcontrib><creatorcontrib>Rieu, Philippe</creatorcontrib><creatorcontrib>Monteiro, Renato C.</creatorcontrib><creatorcontrib>Touré, Fatouma</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berthelot, Laureline</au><au>Robert, Thomas</au><au>Vuiblet, Vincent</au><au>Tabary, Thierry</au><au>Braconnier, Antoine</au><au>Dramé, Moustapha</au><au>Toupance, Olivier</au><au>Rieu, Philippe</au><au>Monteiro, Renato C.</au><au>Touré, Fatouma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2015-10-01</date><risdate>2015</risdate><volume>88</volume><issue>4</issue><spage>815</spage><epage>822</epage><pages>815-822</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, frequently leads to end-stage renal disease and kidney transplantation. However, disease recurrence often occurs after transplantation. Here we evaluated the predictive value of three markers for IgAN recurrence: the presence of galactose-deficient IgA1, IgG anti-IgA autoantibodies, and IgA-soluble (s) CD89 complexes. This was analyzed in 38 kidney transplant recipients with IgAN recurrence and compared with 22 patients transplanted for IgAN but without recurrence and with 17 healthy controls. Pre-transplantation galactose-deficient IgA1 serum levels were significantly higher in the recurrence compared with the no recurrence or control groups. IgA–IgG complexes were significantly elevated in the recurrence group. Both the recurrence and no recurrence groups had increased values of IgA–sCD89 complexes compared with healthy controls, but values were significantly lower in patients with recurrence compared with no recurrence. Areas under the receiver operating curve of the markers in pre-transplantation sera were 0.86 for galactose-deficient-IgA, 0.82 for IgA–IgG, and 0.78 for sCD89–IgA; all significant. Disease recurrence was associated with decreased serum galactose-deficient IgA1 and appearance of mesangial-galactose-deficient IgA1 deposits, whereas increased serum IgA–sCD89 complexes were associated with mesangial sCD89 deposits. Thus, galactose-deficient-IgA1, IgG autoantibodies, and IgA–sCD89 complexes are valuable biomarkers to predict disease recurrence, highlighting major pathogenic mechanisms in IgAN.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26061544</pmid><doi>10.1038/ki.2015.158</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0085-2538 |
| ispartof | Kidney international, 2015-10, Vol.88 (4), p.815-822 |
| issn | 0085-2538 1523-1755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1718912742 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adult Aged Antigen-Antibody Complex - blood Antigens, CD - blood Area Under Curve Autoantibodies - blood autoantibody Biomarkers - blood Biopsy Case-Control Studies Disease Progression Female Glomerulonephritis, IGA - blood Glomerulonephritis, IGA - diagnosis Glomerulonephritis, IGA - immunology Glomerulonephritis, IGA - surgery Humans IgA glycosylation IgA nephropathy Immunoglobulin A - blood Kidney - immunology Kidney - pathology Kidney Failure, Chronic - blood Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - immunology Kidney Failure, Chronic - surgery Kidney Transplantation Male Middle Aged Predictive Value of Tests Receptors, Fc - blood Recurrence Risk Factors ROC Curve sCD89 Treatment Outcome |
| title | Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T23%3A01%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrent%20IgA%20nephropathy%20is%20predicted%20by%20altered%20glycosylated%20IgA,%20autoantibodies%20and%20soluble%20CD89%20complexes&rft.jtitle=Kidney%20international&rft.au=Berthelot,%20Laureline&rft.date=2015-10-01&rft.volume=88&rft.issue=4&rft.spage=815&rft.epage=822&rft.pages=815-822&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1038/ki.2015.158&rft_dat=%3Cproquest_cross%3E1718912742%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1717542746&rft_id=info:pmid/26061544&rft_els_id=S2157171615322437&rfr_iscdi=true |